TSBX Turnstone Biologics
- 2.870
- -0.160-5.28%
- 2.900
- +0.030+1.05%
Turnstone Biologics News
Turnstone Biologics | 10-Q: Quarterly report
Express News | Turnstone Biologics: Expects Combined Cash, Cash Equivalents and Short-Term Investments Will Be Sufficient to Fund Its Operations Into Q3 2025
Express News | Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Express News | Turnstone Biologics Q1 Income From Operations USD -20.691 Million
Express News | Turnstone Biologics Q1 Pretax Profit USD -19.613 Million
Express News | Turnstone Biologics Q1 Operating Expenses USD 20.691 Million
Express News | Turnstone Biologics Q1 Net Income USD -19.629 Million
Express News | Turnstone Biologics Q1 EPS USD -0.85
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to tr
Express News | Turnstone Biologics Appoints William Waddill to Its Board of Directors
Turnstone Biologics GAAP EPS of -$0.73 Beats by $0.25
Express News | Turnstone Biologics Q4 EPS $(0.73) Beats $(0.86) Estimate
Turnstone Biologics: Lead Program, TIDAL-01, Advancing in Phase 1 Trials With Initial Clinical Data Expected in Mid-2024 >TSBX
Turnstone Biologics: Lead Program, TIDAL-01, Advancing in Phase 1 Trials With Initial Clinical Data Expected in Mid-2024 >TSBX
Turnstone Biologics Expects Cash, Cash Equivalents and Short-Term Investments Will Be Sufficient to Fund Ops Into 2Q of 2025 >TSBX
Turnstone Biologics Expects Cash, Cash Equivalents and Short-Term Investments Will Be Sufficient to Fund Ops Into 2Q of 2025 >TSBX
Turnstone Biologics 4Q Loss/Shr 73c >TSBX
Turnstone Biologics 4Q Loss/Shr 73c >TSBX
Press Release: Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights Lead program, TIDAL-01, advancing in Phase 1 trials with initial clinical
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersEtao International Co (NASDAQ:ETAO) stock rose 249.4% to $0.5 during Tuesday's after-market session. The company's market cap stands at $51.1 million. Taysha Gene Therapies (NASDAQ:TSHA) shares
12 Health Care Stocks Moving In Friday's Intraday Session
GainersPsyence Biomedical (NASDAQ:PBM) stock moved upwards by 137.8% to $3.02 during Friday's regular session. The market value of their outstanding shares is at $40.4 million. Ainos (NASDAQ:AIMD) sto
Turnstone Biologics Updates Presentation for Health Care Conference
Turnstone Biologics (NASDAQ:TSBX) Will Have To Spend Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the
Analysis
Price Target
No Data
